CONCOR, an initiative towards a national registry and DNA-bank of patients with congenital heart disease in the Netherlands: Rationale, design, and first results
Author(s) -
Enno T. van der Velde,
Joris W.J. Vriend,
Marcel M.A.M. Mannens,
Cuno S.P.M. Uiterwaal,
Ronald Brand,
Barbara J.M. Mulder
Publication year - 2005
Publication title -
european journal of epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.825
H-Index - 111
eISSN - 1573-7284
pISSN - 0393-2990
DOI - 10.1007/s10654-005-4264-9
Subject(s) - medicine , epidemiology , public health , heart disease , family medicine , disease , pediatrics , pathology
Survival of patients with congenital heart disease has dramatically improved after surgical repair became available 40 years ago. Instead of a mortality of 85% during childhood following the natural course, over 85% of these infants are now expected to reach adulthood. However, data on long-term outcome is scarce due to the lack of large, national registries. Moreover, little is known about the genetic basis of congenital heart defects. In 2000, the Interuniversity Cardiology Institute of the Netherlands and the Netherlands Heart Foundation have taken the initiative to develop a national registry and DNA-bank of patients with congenital heart disease in the Netherlands named CONCOR.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom